Licata & Tyrrell P.C. - Biotechnology
Jane Massey Licata and Kathleen A. Tyrrell have worked together since 1993 to creatively and effectively protect cutting edge inventions. Working with scientists at non-profit research institutions and companies across the U.S. and around the world, Licata & Tyrrell have been translating science into invention®. A keen understanding of the technology and the law and of the research culture and environment have resulted in issuance of groundbreaking patents covering stem cells, antisense therapeutics, gene therapy, molecular diagnostics, new drug targets and new uses for their clients. Expertise and experience in both the intellectual property and regulatory arenas allow clients to move from concept to product to market seamlessly with a single law firm. Licata & Tyrrell work with their clients to develop strategic approaches to creating and building strong, worldwide patent portfolios which are licensed by leading biotechnology and pharmaceutical companies as well as consumer companies focused in the health and wellness sector. Licata & Tyrrell also understand the requirements and challenges for patenting and developing technology in a startup environment and work with innovators and the venture community to develop IP that can be scaled up and commercialized with partners. Licata & Tyrrell also provides expertise and deep experience in creating and maintaining FTO, due diligence for M&A and developing competitive strategies in challenging IP and regulatory landscapes.
Jane Massey Licata, J.D. and Ph.D. has a strong background in biology and biochemistry and has extensive experience in IP and regulatory compliance and approvals. She is licensed to practice law in Pennsylvania, New Jersey and Florida and is a registered US Patent Attorney. She also teaches at Rutgers and Drexel University in the areas of IP, Healthcare and FDA law.